How will Dr. Pazdur’s New Role Affect the Future of FDA Advisory Committees?
Among all the changes at the FDA in 2025, one recent shift that has drawn high praise from the medical community is the appointment of Dr. Richard Pazdur as director of the Center for Drug Evaluation and Research (CDER). A 26-year FDA veteran, Dr. Pazdur is known as an innovator for driving the development of…